ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, I…
- Recall date
- June 20, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0521-2025
- FDA classification
- Class II
- Brand / firm
- ACCORD HEALTHCARE, INC.
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Subpotent Drug: Assay below the approved specification
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-451-17
Get recall alerts
Free email alert whenever ACCORD HEALTHCARE, INC. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ACCORD HEALTHCARE, INC.